Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection.

作者: Y Zhang , Z Qu , S Kim , V Shi , B Liao

DOI: 10.1038/GT.2010.133

关键词:

摘要: Usually, small interfering RNAs and most antisense molecules need mechanical or chemical delivery methods to down-modulate the targeted mRNA. However, these approaches complicate interpretations of biological consequences. We show that locked nucleic acid (LNA)-based oligonucleotides (LNA–ONs) readily genes interest in multiple cell lines without any means. The down-modulation was quick, robust, long-lasting specific followed by potent protein. efficiency effect varied among 30 tumor investigated. robust effects were found those cells where nuclear localization LNA–ON clearly observed. Importantly, using agent, we demonstrated HER3 mRNA protein could be efficiently down-modulated a xenograft model. These data provide simple efficient approach identify potential drug targets animal models. Further elucidation mechanism cellular uptake trafficking LNA–ONs may enhance not only therapeutic values this platform but also general.

参考文章(31)
Dietmar Rabussay, Applicator and electrode design for in vivo DNA delivery by electroporation. Methods of Molecular Biology. ,vol. 423, pp. 35- 59 ,(2008) , 10.1007/978-1-59745-194-9_3
Wengel J, Orum H, Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development. Current Opinion in Molecular Therapeutics. ,vol. 3, pp. 239- ,(2001)
Anneloor L. M. A. ten Asbroek, Marjon van Groenigen, Marleen Nooij, Frank Baas, The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides European Journal of Biochemistry. ,vol. 269, pp. 583- 592 ,(2002) , 10.1046/J.0014-2956.2001.02686.X
Sara Cherry, What have RNAi screens taught us about viral-host interactions? Current Opinion in Microbiology. ,vol. 12, pp. 446- 452 ,(2009) , 10.1016/J.MIB.2009.06.002
Jan Stenvang Jepsen, Mads D. Sørensen, Jesper Wengel, Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology. Oligonucleotides. ,vol. 14, pp. 130- 146 ,(2004) , 10.1089/1545457041526317
Elizabeth Rose Rayburn, Hui Wang, Ruiwen Zhang, Antisense-based cancer therapeutics: are we there yet? Expert Opinion on Emerging Drugs. ,vol. 11, pp. 337- 352 ,(2006) , 10.1517/14728214.11.2.337
José Baselga, Sandra M. Swain, Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 Nature Reviews Cancer. ,vol. 9, pp. 463- 475 ,(2009) , 10.1038/NRC2656
Arnold Gr??nweller, Roland K Hartmann, Locked nucleic acid oligonucleotides: the next generation of antisense agents? BioDrugs. ,vol. 21, pp. 235- 243 ,(2007) , 10.2165/00063030-200721040-00004
Aimee L Jackson, Steven R Bartz, Janell Schelter, Sumire V Kobayashi, Julja Burchard, Mao Mao, Bin Li, Guy Cavet, Peter S Linsley, Expression profiling reveals off-target gene regulation by RNAi Nature Biotechnology. ,vol. 21, pp. 635- 637 ,(2003) , 10.1038/NBT831